Alar Pharmaceuticals Inc. (TPEX:6785)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
117.00
-0.50 (-0.43%)
At close: Jul 9, 2026
Market Cap7.82B -17.0%
Revenue (ttm)3.00M -48.4%
Net Income-112.77M
EPS-1.69
Shares Out 66.80M
PE Ration/a
Forward PEn/a
Dividend0.10 (0.09%)
Ex-Dividend DateJun 10, 2025
Volume100,909
Open118.50
Previous Close117.50
Day's Range115.50 - 120.00
52-Week Range111.00 - 317.00
Beta0.08
Analystsn/a
Price Targetn/a
Earnings DateAug 7, 2026

About Alar Pharmaceuticals

Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan. [Read more]

Sector Healthcare
Founded 2016
Employees 32
Stock Exchange Taipei Exchange
Ticker Symbol 6785
Full Company Profile

Financial Performance

Financial Statements